---
title: "Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286757134.md"
description: "Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News"
datetime: "2026-05-18T02:45:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286757134.md)
  - [en](https://longbridge.com/en/news/286757134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286757134.md)
---

# Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 | CNTX Stock News

### Related Stocks

- [CNTX.US](https://longbridge.com/en/quote/CNTX.US.md)
- [BCAB.US](https://longbridge.com/en/quote/BCAB.US.md)

## Related News & Research

- [LifeSci Capital downgrades Context Therapeutics (CNTX) to a Hold](https://longbridge.com/en/news/295149457.md)
- [Context drops bispecific T-cell engager on cost-cutting initiative](https://longbridge.com/en/news/295244834.md)
- [Bradley Foster & Sargent Inc. CT Has $283.06 Million Holdings in Alphabet Inc. $GOOGL](https://longbridge.com/en/news/294926146.md)
- [QT Imaging names Jason Dyer, Dave Reinhart as regional sales VPs in US push](https://longbridge.com/en/news/294824635.md)
- [FST says TaylorMade selects KBS putter shafts as stock option for new Spider Tour, Spider ZT Max lines](https://longbridge.com/en/news/294887067.md)